MedPath

Study of the efficacy and safety of intra-retinal arterial fibrinolysis for central retinal artery occlusio

Not Applicable
Recruiting
Conditions
Central Retinal Artery Occlusion(CRAO)
Registration Number
JPRN-UMIN000022972
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who may have side effects by tPA 2)Pregnancy 3)Patients judged to be appropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual acuity 24 weeks after surgery
Secondary Outcome Measures
NameTimeMethod
1) Improvement of visual acuity from baseline to 24 weeks after surgery 2) Change of retinal thickness from baseline to 24 weeks after surgery 3) Laser speckle from baseline to 24 weeks after surgery 4) Occurrence rate of surgical complications 5) Vison loss
© Copyright 2025. All Rights Reserved by MedPath